You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine

Showing 26 - 50 of 2,013
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

Completed
  • Neuroendocrine Tumors
  • Innsbruck, Austria
    Department of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation
  • GEP-NET
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 24, 2023

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

    Not yet recruiting
    • Bronchial and Thymic Neuroendocrine Tumour
    • +3 more
    • Lu-177 DOTATATE (Lutathera®)
    • (no location specified)
    Nov 1, 2023

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    Collect Somatuline® Injector Device Preferences of Patients

    Not yet recruiting
    • Neuroendocrine Tumors
      • (no location specified)
      Jun 19, 2023

      Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

      Not yet recruiting
      • Advanced Gastroenteropancreatic Neuroendocrine Tumor
      • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
      • long-acting Octreotide.
      • (no location specified)
      May 22, 2023

      Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

      Not yet recruiting
      • Neuroendocrine Neoplasms
      • BI 764532
      • +3 more
      • (no location specified)
      Nov 10, 2023

      Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

      Not yet recruiting
      • Neuroendocrine Tumors
      • +8 more
      • Iowa City, Iowa
      • +1 more
      Nov 23, 2022

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

      Recruiting
      • Neuroendocrine Tumor
      • Beijing, Chao Yang, China
        National Cancer Center/Cancer Hospital,Chinese Academy of Medica
      Feb 19, 2023

      Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)

      Not yet recruiting
      • Neuroendocrine Carcinoma
      • Surufatinib and Serplulimab
      • Wuhan, Hubei, China
        Cancer Center, Union Hospital, Tongji Medical College, Huazhong
      Feb 18, 2023

      Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

      Recruiting
      • Neuroendocrine Tumors
      • Al18F-NOTA-LM3
      • +2 more
      • Beijing, China
        Peking Union Medical College Hospital
      Sep 20, 2023

      Epiction of Genomic and Genetic Landscape Identifies CCL5

      Completed
      • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
        • (no location specified)
        Jan 27, 2023

        Frequency for Patients With Gastric Neuroendocrine Carcinoma

        Completed
        • Gastric Neuroendocrine Carcinoma
          • Fuzhou, Fujian, China
            Chang-ming Huang
          Dec 31, 2022

          Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

          Not yet recruiting
          • Small Cell Lung Carcinoma (SCLC)
          • Neuroendocrine Neoplasms
          • BI 764532
          • [89Zr]Zr-BI 764532
          • (no location specified)
          Jul 31, 2023

          Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

          Recruiting
          • Gastroenteropancreatico Tumors
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 19, 2023

          Menopause Trial in Nanjing (Femoston, Qingxin Zishen Decoction)

          Completed
          • Menopause
          • Nanjing, 南京, China
            Yuxin Zhou
          Nov 9, 2023

          Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

          Recruiting
          • Neuroendocrine Neoplasm
          • Beijing, China
            Chinese PLA General Hospital
          May 25, 2023

          Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

          Completed
          • Recurrent Neuroendocrine Tumor
          • Metastatic Neuroendocrine Tumor
          • Cleveland, Ohio
            Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
          Dec 1, 2022

          Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

          Recruiting
          • Locally Advanced Neuroendocrine Neoplasm
          • Metastatic Neuroendocrine Neoplasm
          • Placebo Administration
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 31, 2023

          VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

          Recruiting
          • VHL Pancreatic Neuroendocrine Tumors
          • +2 more
          • 68-Gallium DOTATATE
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 26, 2023

          Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

          Not yet recruiting
          • Neuroendocrine Tumors
          • Lutetium[177Lu] Oxodotreotide Injection
          • Beijing, Beijing, China
            Beijing Cancer Hospital
          May 30, 2023

          Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

          Not yet recruiting
          • Advanced Prostate Cancer
          • +2 more
          • Boston, Massachusetts
          • +1 more
          Sep 25, 2023

          Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

          Not yet recruiting
          • Small Cell Lung Cancer (SCLC)
          • +3 more
          • (no location specified)
          Dec 7, 2022